Diabetic retinopathy in Down's syndrome

British Journal of Ophthalmology

Volumn 82, Issue 4, 1998, Pages 407-409

  Fulcher, Tim ^a,b   Griffin, Margaret ^a   Crowley, Seamus ^a   Firth, Richard ^a   Acheson, Robert ^a   O'Meara, Niall ^a,b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b Institute of Ophthalmology   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE DURATION; DOWN SYNDROME; FEMALE; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; RETINOPATHY; URINALYSIS;

EID: 0031966410     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.4.407     Document Type: Article

References (25)

1. Dahl-Jorgenson K, Brinchman-Hanson O, Hanssen KF, Sandvik L, and the Aker Diabetes Group. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin-dependent diabetes mellitus. The Oslo study. BMJ 1985;290:811-5.
2. Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria. N Engl J Med 1984;311:365-72.
3. Lauritzen T, Larsen HW, Frost-Larsen K, Deckert T, and The Steno Study Group. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin dependent diabetics. Lancet 1983;i:200-4.
4. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
5. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. 2 Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102: 520-6.
6. Knowler WC, Bennett PH, Ballintine EJ. Increased incidence of retinopathy in diabetics with elevated blood pressure: a six-year follow-up study in Pima Indians. N Engl J Med 1980;302:645-50.
7. Kornerup T. Studies in diabetic retinopathy: an investigation of 1,000 cases of diabetes. Acta Med Scand 1955;153: 81-101.
8. Becker B. Diabetes and glaucoma. In: Kimura SJ, Caygill, WM, eds. Vascular complications of diabetes mellitus. St Louis: Mosby Yearbook, 1967:43-8.
9. Jain IS, Luthra CL, Das T. Diabetic retinopathy and its relation to errors of refraction. Arch Ophthalmol 1967;77:59-60.
10. Rand LI, Krolewski AS, Aiello LM, et al. Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med 1985;313:1433-8.
11. Gay AJ, Rosenbaum AL. Retinal artery pressure in asymmetric diabetic retinopathy. Arch Ophthalmol 1966;75: 758-62.
12. Blankenship GW, Skyler JS. Diabetic retinopathy: a general survey. Diabetes Care 1978;1:127-37.
13. Szabo AJ, Stewart AG, Joron GE. Factors associated with increased prevalence of diabetic retinopathy. Can Med Assoc J 1967;97:286-92.
14. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX Four year incidence and progression of retinopathy when the age at diagnosis is less than 30 years. Arch Ophthalmol 1989;107:237-43.
15. Klein R, Klein BEK, Moss SE, DeMets DL. Blood pressure and hypertension in diabetes. Am J Epidemiol 1985;122:75-89.
16. Chase HP, Garg SK, Jackson WE, et al. Blood pressure and retinopathy in type 1 diabetes. Ophthalmology 1990;97: 155-9.
17. Lewis JM, Jovanovic-Peterson L, Ahmadizadeh I, et al. The Santa Barbara County diabetic retinopathy screening feasibility study: significance of diabetes duration and systolic blood pressure. J Diabetes Complications 1994;8:51-4.
18. Cignareeli M, DeCicco ML, Damato A, et al. High systolic blood pressure increases prevalence and severity in NIDDM patients. Diabetes Care 1992;15:1002-8.
19. Kohner EM, Patel V, Rassam SMB. Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 1995;44:603-7.
20. Patel V, Rassam S, Newsom R, Wiek J, Kohner E. Retinal blood flow in diabetic retinopathy. BMJ 1992;305:678-83.
21. Anneren G, Gustafsson J, Sara VR, Tuvemo T. Normalised growth velocity in children with Down's syndrome during growth hormone therapy. J Intellect Disabil Res 1993;37: 381-7.
22. Barreca A, Rasore-Quartino A, Actis MS, et al. Assessment of growth hormone insulin like growth factor-1 axis in Down's syndrome. J Endocrinol Invest 1994;17:431-6.
23. Castells S, Torrado C, Bastian W, Wisniewski KE. Growth hormone deficiency in Down's syndrome children. J Intellect Disabil Res 1992;36:29-43.
24. Alzaid AA, Dinneen SF, Melton LJ, Rizza RA. The role of growth hormone in the development of diabetic retinopathy. Diabetes Care 1994;17:531-4.
25. Merimee TJ. Comparative metabolic and clinical studies of sexual ateliotic dwarfs and diabetics in Camerini. Vascular and neurological changes in early diabetes. New York: Academic Press, 1978:207-13.